Astera Labs, Inc. Common Stock
NASDAQ:ALABSemiconductors
+$39.44 today
- Market cap
- $37.88B
- Beta
- 3.96
- P/E (TTM)
- 264.2
- EPS (TTM)
- $1.57
Volume 4.57M
Average 5.72M
ALAB Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Astera Labs, Inc. Common StockNASDAQ: ALAB
Research & Development · Q2 FY2026 · quarter ended Jun 2026
Research & development growth accelerates
Q2 FY2026 research & development of $135.9M rose 103.7% year over year, ahead of the +82.1% change in trailing-twelve-month research & development. Sequentially, it rose 8.2% from the prior quarter. Over 3 fiscal years it compounded at +60.4% a year.
Context
- Research & development amounted to 35.7% of revenue in FY2025, down 15.0 pp from a year earlier.
- Research & development increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +103.7% holds above the trailing-twelve-month pace of +82.1%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 304M USD
- Year-over-year change
- +51.4%
- 3-year CAGR
- +60.4%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 304M | +51.4% |
| FY2024 | 2024-12-31 | 200.83M | +173.6% |
| FY2023 | 2023-12-31 | 73.41M | -0.4% |
| FY2022 | 2022-12-31 | 73.71M | — |
Research & Development vs competitors
How ALAB compares with its peers on the latest reported figures
- ALAB's LTM Jun 2026 research & development of $434.25M is the 5th highest of the 7 companies compared; the peer median is $1.45B.
- Its year-over-year change of +82.1% is the 2nd highest of 7, against a peer median of +16.6%.
- Research & development amounts to 36.1% of revenue for ALAB, versus a peer median of 17.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Aug 2026 | $2.44B | +21.2% | +5.2% | 25.8% | |
| LTM Sep 2026 | $2.1B | +2.1% | +7.6% | 10.1% | |
| LTM Aug 2026 | $1.98B | +17.8% | +1.3% | 14.2% | |
| LTM Jun 2026 | $919M | +15.3% | +10.8% | 4.8% | |
| LTM Jun 2026 | $434.25M | +82.1% | +60.4% | 36.1% | |
| LTM Aug 2026 | $341.46M | +103.2% | +53.8% | 21.5% | |
| LTM Sep 2026 | $221.53M | +6.4% | -11.1% | 33.5% | |
| Peer median (excluding ALAB) | $1.45B | +16.6% | +6.4% | 17.9% | |
Competitors are the stored peer set for ALAB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Revenue | 79.87M | 115.79M | 396.29M | 852.53M |
| Cost of Revenue | 21.19M | 35.97M | 93.59M | 207.26M |
| Gross Profit | 58.68M | 79.83M | 302.7M | 645.26M |
| Gross Margin | 73.5% | 68.9% | 76.4% | 75.7% |
| Research & Development | 73.71M | 73.41M | 200.83M | 304M |
| Selling, General & Admin | 45.16M | 35.92M | 217.94M | 167.84M |
| Operating Expenses | 118.88M | 109.32M | 418.77M | 471.84M |
| Depreciation & Amortization | 807K | 1.78M | 3.15M | 6.83M |
| EBITDA | (56.77M) | (21.17M) | (78.62M) | 224.98M |
| EBITDA Margin | -71.1% | -18.3% | -19.8% | 26.4% |
| Operating Income | (60.19M) | (29.5M) | (116.07M) | 173.42M |
| Operating Margin | -75.4% | -25.5% | -29.3% | 20.3% |
| Interest Income | 2.61M | 6.55M | 34.29M | 44.73M |
| Interest Expense | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 2.61M | 6.55M | 34.29M | 44.73M |
| Income Before Tax | (57.58M) | (22.95M) | (81.78M) | 218.15M |
| Pre-Tax Margin | -72.1% | -19.8% | -20.6% | 25.6% |
| Income Tax Expense | 764K | 3.31M | 1.64M | (981K) |
| Net Income | (58.35M) | (26.26M) | (83.42M) | 219.13M |
| Net Margin | -73.0% | -22.7% | -21.1% | 25.7% |
| EPS (Basic) | (0.45) | (0.17) | (0.64) | 1.32 |
| EPS (Diluted) | (0.45) | (0.17) | (0.64) | 1.22 |
| Weighted Avg Shares | 130.45M | 152.5M | 131.26M | 166.41M |
| Weighted Avg Shares (Diluted) | 130.45M | 152.5M | 131.26M | 179.55M |
Astera Labs, Inc. Common Stock
NASDAQ:ALAB
Intrinsic Alpha fair value
Locked
Current Price
$216.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.